Nantahala Capital Management »

Aquestive Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4M 600k 5.59

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Perceptive Advisors
EcoR1 Capital
Samsara BioCapital
Geode Capital Management
State Street Corporation
Sio Capital Management
Susquehanna International
Morgan Stanley
Millennium Management
Blue Owl Capital Holdings
Janney Montgomery Scott

View all funds holding Aquestive Therapeutics